| Indicators | Browse All

Evaxion A/S (EVAX)

Healthcare | Biotechnology | Horsholm, Denmark | NasdaqCM
2.83 USD +0.03 (1.086%) ⇧ (Oct. 15, 2026, 11:36 a.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 4:39 a.m. EDT

The immediate outlook is severely clouded by a relentless multi-year decline in shareholder value, evidenced by a trailing run of down years that has dragged the stock price down significantly from its highs. This structural deterioration is compounded by deteriorating fundamentals, specifically negative profit margins and negative free cash flow, which suggest the business is currently burning capital without generating returns. The lack of any dividend payout eliminates income appeal entirely. While the balance sheet appears robust with a fortress-like current ratio, this liquidity cannot offset the reality of a company that is losing money and whose stock has been punished by the market for years. The recent news of promising preclinical data offers a glimmer of hope for future recovery, but it is insufficient to overcome the weight of the current financial bleed and the long-term price trajectory.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.045243
MSTL0.047709
AutoTheta0.155084
AutoARIMA0.183433

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 45%
H-stat 1.15
Ljung-Box p 0.000
Jarque-Bera p 0.457
Excess Kurtosis -0.65
Attribute Value
Sector Healthcare
Debt to Equity Ratio 74.546
Revenue per Share 0.942
Market Cap 25,534,406
Forward P/E -188.69
Beta 0.51
Profit Margins -115.54%
Previous Name Evaxion Biotech A/S
Website https://evaxion.ai

Info Dump

Attribute Value
52 Week Change -0.7083334
Address1 Dr. Neergaards Vej
Address2 5th Floor
All Time High 1,252.0
All Time Low 1.2
Ask 4.09
Ask Size 2
Average Analyst Rating 1.3 - Strong Buy
Average Daily Volume10 Day 50,470
Average Daily Volume3 Month 203,290
Average Volume 203,290
Average Volume10Days 50,470
Beta 0.511
Bid 2.31
Bid Size 2
Book Value 1.143
City Horsholm
Compensation As Of Epoch Date 1,767,139,200
Country Denmark
Crypto Tradeable 0
Currency USD
Current Price 2.8304
Current Ratio 5.062
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 2.9
Day Low 2.8
Debt To Equity 74.546
Display Name Evaxion
Dividend Yield 0.0
Earnings Call Timestamp End 1,748,349,000
Earnings Call Timestamp Start 1,748,349,000
Earnings Timestamp End 1,755,520,200
Earnings Timestamp Start 1,755,001,800
Ebitda -8,326,000
Ebitda Margins -1.11147
Enterprise To Ebitda -1.977
Enterprise To Revenue 2.197
Enterprise Value 16,457,602
Eps Current Year -0.04
Eps Forward -0.015
Eps Trailing Twelve Months -1.03
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.14452
Fifty Day Average Change -0.31412005
Fifty Day Average Change Percent -0.099894434
Fifty Two Week Change Percent -70.833336
Fifty Two Week High 11.51
Fifty Two Week High Change -8.6796
Fifty Two Week High Change Percent -0.75409204
Fifty Two Week Low 2.72
Fifty Two Week Low Change 0.11039996
Fifty Two Week Low Change Percent 0.040588222
Fifty Two Week Range 2.72 - 11.51
Financial Currency USD
First Trade Date Milliseconds 1,612,535,400,000
Float Shares 5,679,353
Forward Eps -0.015
Forward P E -188.69334
Free Cashflow -5,487,625
Full Exchange Name NasdaqCM
Full Time Employees 46
Fullday Change 0.030400038
Fullday Change Percent 1.0857157
Fullday Price 2.8304
Gmt Off Set Milliseconds -14,400,000
Gross Margins 1.0
Gross Profits 7,491,000
Has Pre Post Market Data 1
Held Percent Insiders 0.16149999
Held Percent Institutions 0.094160005
Implied Shares Outstanding 9,021,483
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,021-02-05
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,736,812,800
Last Split Factor 1:5
Long Business Summary Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Long Name Evaxion A/S
Market us_market
Market Cap 25,534,406
Market State REGULAR
Max Age 86,400
Message Board Id finmb_319014926
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-15
Net Income To Common -8,655,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 29,591,366
Number Of Analyst Opinions 4
Open 2.8
Operating Cashflow -7,164,000
Operating Margins -1.16019
Phone 45 53 53 18 50
Prev Name Evaxion Biotech A/S
Previous Close 2.8
Price Eps Current Year -70.76
Price Hint 4
Price To Book 2.4762905
Price To Sales Trailing12 Months 3.4086778
Profit Margins -1.15539
Quick Ratio 4.736
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.25
Region US
Regular Market Change 0.030400038
Regular Market Change Percent 1.0857157
Regular Market Day High 2.9
Regular Market Day Low 2.8
Regular Market Day Range 2.8 - 2.9
Regular Market Open 2.8
Regular Market Previous Close 2.8
Regular Market Price 2.8304
Regular Market Time 1,792,078,587
Regular Market Volume 17,224
Return On Assets -0.25972
Return On Equity -1.09856
Revenue Per Share 0.942
Sand P52 Week Change 0.16440773
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 9,021,483
Shares Percent Shares Out 0.0056
Shares Short 50,577
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 56,514
Short Name Evaxion A/S
Short Percent Of Float 0.0067000003
Short Ratio 1.06
Source Interval 15
Symbol EVAX
Target High Price 16.0
Target Low Price 9.0
Target Mean Price 11.25
Target Median Price 10.0
Total Cash 14,000,000
Total Cash Per Share 1.679
Total Debt 7,105,000
Total Revenue 7,491,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.03
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.60378
Two Hundred Day Average Change -0.77338004
Two Hundred Day Average Change Percent -0.21460246
Type Disp Equity
Volume 17,224
Website https://evaxion.ai
Zip 2,970